ARCHIVES

FDA Approves 35 Medicines In Fiscal 2012, Eight in Cancer

This article is from The Cancer Letter archive.

Vol. 35 No. 12 | December 28, 2012

Download PDF Visit The Full Archive

Related Articles

Going private may allow US Oncology to restructure, respond to Medicare cuts; equity investment firm offers to purchase shares.

April 23, 2004

Perifosine, Sorafenib Combination Well Tolerated in Several Lymphomas

December 28, 2012

Brothers Of Prostate Cancer Patients At Risk Of Diagnosis

August 27, 2010

November issue of Business & Regulatory Report included.

November 28, 2003

Weicker Compromise on 6,000 Grants For Two Years Holds Up; New Waxman Bill Would Renew Cancer Act

May 17, 1985

Top Management Shifts At Bristol-Myers Squibb Oncology, R&D Units

October 6, 1995